GU Cancers 2023 | How real-time molecular imaging can improve the management of prostate cancer

Anthony Victor D’Amico, MD, PhD, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA, discusses how radiotherapy for prostate cancer has evolved over the last 30 years and talks on some of the remaining unmet needs in the field. A key area which needs further research is the use of real-time molecular imaging, which would allow clinicians to understand how the disease is evolving and developing and help them to decide how best to use highly precise local treatment. Prof. D’Amico also highlights the importance of preserving important structures in the prostate, which are at risk of damage when high-dose, short duration radiotherapy is used. Finally, Prof. D’Amico talks on the need to understand how best to combine radiotherapy with appropriate systemic therapies. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.